1-[2-((3,4-dichlorophenyl)-5-methyl-1H-1,2,4-triazole-3-yl-thio)ethyl]piperidine oxalate | 1025011-06-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 1-[2-((3,4-dichlorophenyl)-5-methyl-1H-1,2,4-triazole-3-yl-thio)ethyl]piperidine oxalate
• 英文别名: 1-[2-[[1-(3,4-Dichlorophenyl)-5-methyl-1,2,4-triazol-3-yl]sulfanyl]ethyl]piperidine;oxalic acid
• CAS: 1025011-06-6
• 化学式: C₂H₂O₄*C₁₆H₂₀Cl₂N₄S
• 分子量: 461.369
• InChiKey: UNPKAKRVWIQVAD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.62
• 重原子数：
  29
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  134
• 氢给体数：
  2
• 氢受体数：
  8

文献信息

• Sigma ligands for use in the prevention and/or treatment of postoperative pain
  申请人：Laboratorios del. Dr. Esteve, S.A.

  公开号：EP2353598A1

  公开（公告）日：2011-08-10

  The invention refers to the use of a sigma ligand, particularly a sigma ligand of formulae (I), (II) or (III) to prevent and/or treat acute and chronic pain developed as a consequence of surgery, especially superficial and/or deep pain secondary to surgical tissue injury, and peripheral neuropathic pain, neuralgia, allodynia, causalgia, hyperalgesia, hyperesthesia, hyperpathia, neuritis or neuropathy secondary to surgical procedure.

  本发明涉及使用sigma配体，特别是公式（I），（II）或（III）的sigma配体，以预防和/或治疗由手术引起的急性和慢性疼痛，特别是手术组织损伤引起的表浅和/或深层疼痛，以及周围神经病理性疼痛，神经痛，触痛，烧伤性痛，痛觉过敏，疼痛过敏，神经炎或手术过程引起的神经病变。
• 1,2,4-TRIAZOLE DERIVATIVES AS SIGMA RECEPTOR INHIBITORS
  申请人：Jagerovic Nadine

  公开号：US20120004211A1

  公开（公告）日：2012-01-05

  The invention relates to the use of compounds having pharmacological activity towards the sigma receptor, and more particularly to 1,2,4-triazole derivatives of formula I to processes of preparation of such compounds and to pharmaceutical compositions comprising them.

  本发明涉及使用具有对sigma受体具有药理活性的化合物，更具体地涉及公式I的1,2,4-三唑衍生物的制备过程以及包含它们的药物组合物。
• Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
  申请人：Laboratorios del. Dr. Esteve, S.A.

  公开号：EP2388005A1

  公开（公告）日：2011-11-23

  The invention refers to the use of a sigma ligand, preferably a sigma ligand of formula (I), to prevent or treat emesis induced by a chemotherapeutic agent or radioactivity, especially emesis induced by taxanes, vinca alkaloids or platin chemotherapeutic drugs.

  本发明是指使用σ配体，最好是式(I)的σ配体，来预防或治疗由化疗药物或放射性诱发的呕吐，特别是由紫杉类、长春花生物碱或铂类化疗药物诱发的呕吐。
• Use of sigma ligands in opioid-induced hyperalgesia
  申请人：Laboratorios del. Dr. Esteve, S.A.

  公开号：EP2415471A1

  公开（公告）日：2012-02-08

  The invention refers to the use of a sigma ligand, particularly a sigma ligand of formula (I) to prevent and/or treat opioid-induced hyperalgesia (OIH) associated to opioid therapy.

  本发明是指使用σ配体，特别是式(I)的σ配体来预防和/或治疗与阿片类药物治疗相关的阿片类药物诱导的痛觉减退（OIH）。
• Use of sigma ligands in bone cancer pain
  申请人：Laboratorios del. Dr. Esteve, S.A.

  公开号：EP2460519A1

  公开（公告）日：2012-06-06

  The invention refers to the use of a sigma ligand, particularly a sigma ligand of formula (I) to prevent and/or treat pain associated to bone cancer.

  本发明是指使用σ配体，特别是式(I)的σ配体来预防和/或治疗与骨癌相关的疼痛。